Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Centanni

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Endocrine|September 13, 2014
Thyro-gastric autoimmunity in patients with differentiated thyroid cancer: a prospective studyFrancesco Cicone, Annalisa Papa, Chiara Lauri, et al.
The American Journal of Medicine|February 12, 2008
Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritisEdith Lahner, Marco Centanni, Giacoma Agnello, et al.
Autoimmunity Reviews|July 13, 2017
Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditisSilvia Martina Ferrari, Poupak Fallahi, Giulia Santaguida, et al.
Reviews in Endocrine & Metabolic Disorders|October 12, 2023
The relationship between thyroid and human-associated microbiota: A systematic review of reviewsCamilla Virili, Ilaria Stramazzo, Maria Flavia Bagaglini, et al.
Endocrinology|June 13, 2012
CCAAT/enhancer-binding proteins are key regulators of human type two deiodinase expression in a placenta cell lineGianluca Canettieri, Maria Giulia Santaguida, Laura Antonucci, et al.
European Thyroid Journal|July 7, 2025
ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidismMarco Centanni, Leonidas Duntas, Ulla Feldt-Rasmussen, et al.
Current Medicinal Chemistry|October 10, 2017
Sunitinib in the Treatment of Thyroid CancerSilvia Martina Ferrari, Marco Centanni, Camilla Virili, et al.
Recent Patents on Anti-Cancer Drug Discovery|February 23, 2018
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently AppliedSilvia M Ferrari, Ilaria Ruffilli, Marco Centanni, et al.
Immunobiology|September 5, 2012
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonistsAlessandro Antonelli, Silvia Martina Ferrari, Caterina Mancusi, et al.
Journal of Endocrinological Investigation|April 6, 2026
The role of nutrition on thyroid health and disease: myths and factsRosaria Maddalena Ruggeri, Camilla Virili, Edoardo Mocini, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Endocrine|September 13, 2014
Thyro-gastric autoimmunity in patients with differentiated thyroid cancer: a prospective studyFrancesco Cicone, Annalisa Papa, Chiara Lauri, et al.
The American Journal of Medicine|February 12, 2008
Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritisEdith Lahner, Marco Centanni, Giacoma Agnello, et al.
Autoimmunity Reviews|July 13, 2017
Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditisSilvia Martina Ferrari, Poupak Fallahi, Giulia Santaguida, et al.
Reviews in Endocrine & Metabolic Disorders|October 12, 2023
The relationship between thyroid and human-associated microbiota: A systematic review of reviewsCamilla Virili, Ilaria Stramazzo, Maria Flavia Bagaglini, et al.
Endocrinology|June 13, 2012
CCAAT/enhancer-binding proteins are key regulators of human type two deiodinase expression in a placenta cell lineGianluca Canettieri, Maria Giulia Santaguida, Laura Antonucci, et al.
European Thyroid Journal|July 7, 2025
ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidismMarco Centanni, Leonidas Duntas, Ulla Feldt-Rasmussen, et al.
Current Medicinal Chemistry|October 10, 2017
Sunitinib in the Treatment of Thyroid CancerSilvia Martina Ferrari, Marco Centanni, Camilla Virili, et al.
Recent Patents on Anti-Cancer Drug Discovery|February 23, 2018
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently AppliedSilvia M Ferrari, Ilaria Ruffilli, Marco Centanni, et al.
Immunobiology|September 5, 2012
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonistsAlessandro Antonelli, Silvia Martina Ferrari, Caterina Mancusi, et al.
Journal of Endocrinological Investigation|April 6, 2026
The role of nutrition on thyroid health and disease: myths and factsRosaria Maddalena Ruggeri, Camilla Virili, Edoardo Mocini, et al.
Pageof 8